Lensar LNSR
NASDAQ LNSR
$8.31 -0.29 (-3.37%)
As of: Sep 9, 2026 · 12:57 PM EDT

Lensar (LNSR) Net Shares Issued and Repurchased (2019 - 2025)

Lensar's (LNSR) quarterly Net Shares Issued and Repurchased came in at $23000.0 in Q4 2025, down 85.8% year-over-year from $162000.0 in Q4 2024, and up 228.57% quarter-over-quarter from $7000.0 in Q1 2025.

Analysis

Lensar (LNSR) Net Shares Issued and Repurchased (2019 - 2025) Analysis & Trends

Lensar (LNSR) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $23000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Net Shares Issued and Repurchased fell 85.8% year-over-year to $23000.0 in Q4 2025; TTM through Dec 2025 was $23000.0, a 85.8% decrease from a year earlier, with the FY2025 full-year figure at $23000.0, down 85.8% from the prior year.
  • Net Shares Issued and Repurchased was $23000.0 for Q4 2025 at Lensar, up from $7000.0 in the prior quarter.
  • Over five years, Net Shares Issued and Repurchased peaked at $166.4 million in Q1 2021 and troughed at $7000.0 in Q1 2025.
  • A 5-year average of $17.0 million and a median of $421500.0 in 2022 frame the typical range for Net Shares Issued and Repurchased.
  • Across the five-year window, Net Shares Issued and Repurchased plunged 99.71% in 2022 and jumped 40.88% in 2023, its largest moves.
  • Over 5 years, Net Shares Issued and Repurchased stood at $674000.0 in 2021, then dropped by 12.17% to $592000.0 in 2022, then jumped by 40.88% to $834000.0 in 2023, then slumped by 80.58% to $162000.0 in 2024, then tumbled by 85.8% to $23000.0 in 2025.
  • The last three Net Shares Issued and Repurchased figures came in at $23000.0 (Q4 2025), $7000.0 (Q1 2025), and $162000.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Abbott Laboratories 184.22 Bn 178.62 Bn 7.27 Bn -
2 Intuitive Surgical 124.47 Bn 119.26 Bn 1.96 Bn -
3 Medtronic 118.41 Bn 109.59 Bn 6.34 Bn -
4 Stryker 105.06 Bn 101.58 Bn 4.50 Bn -
5 Boston Scientific 66.48 Bn 65.94 Bn 3.85 Bn -
6 Edwards Lifesciences 49.76 Bn 45.51 Bn 1.35 Bn -
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn -
8 Dexcom 32.33 Bn 30.38 Bn 830.00 Mn -
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn -
10 Lensar 102.19 Mn 88.62 Mn 9.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 23,000.00
Mar 31, 2025 7,000.00
Dec 31, 2024 162,000.00
Mar 31, 2024 108,000.00
Dec 31, 2023 834,000.00
Mar 31, 2023 367,000.00
Dec 31, 2022 592,000.00
Mar 31, 2022 476,000.00
Dec 31, 2021 674,000.00
Mar 31, 2021 166.40 Mn
Dec 31, 2019 1,000.00